Pak-China business moot ends with $1.4bn investment agreements

Pak-China business moot ends with $1.4bn investment agreements
Updated on

Summary One of the major highlights of the event was the signing of final investment agreements for local manufacturing of pharmaceutical products, medical equipment, and vaccines in Pakistan

ISLAMABAD (APP) - Pakistan and China signed investment and business agreements worth approximately US$1.4 billion at the conclusion of the two-day Pakistan-China Business Conference held in Islamabad, marking another significant step towards strengthening bilateral economic and industrial cooperation.

On the final day of the conference, participants signed 42 agreements valued at approximately US$850 million, covering a wide range of sectors, including pharmaceuticals, medical devices, vaccine production, healthcare technology, and industrial manufacturing.

The conference, held on July 17-18th, brought together more than 250 Chinese companies and a large number of Pakistani businesses, creating a platform for business-to-business (B2B) engagements aimed at expanding trade, investment, technology transfer, and industrial collaboration.

One of the major highlights of the event was the signing of final investment agreements for local manufacturing of pharmaceutical products, medical equipment, and vaccines in Pakistan.

These agreements are expected to promote technology transfer, strengthen Pakistan’s healthcare industry, reduce dependence on imports, and create new employment opportunities.

The conference concluded with total investment commitments reaching US$1.4 billion, reflecting the growing confidence of Chinese investors in Pakistan’s economic potential and business environment.

The participating Chinese companies held extensive business-to-business (B2B) meetings with their Pakistani counterparts, exploring opportunities for joint ventures, industrial partnerships, and long-term investment projects across multiple sectors.

The discussions focused on enhancing industrial cooperation, improving supply chains, and increasing local production capacity.

Officials and business leaders described the conference as a milestone in Pakistan-China economic relations, noting that the agreements would contribute to industrial modernization, export promotion, and sustainable economic growth.

The pharmaceutical and healthcare sectors emerged as major beneficiaries of the investment commitments.

The agreements are expected to facilitate the establishment of modern production facilities for medicines, vaccines, and medical equipment, enabling Pakistan to improve domestic manufacturing capabilities while expanding export opportunities to regional and international markets.

Browse Topics